[Aijian Securities] Hongda Hi-Tech: It's better to keep an eye on the long-term, biaxial development of a leading editor
In-depth research on Hongda Hi-Tech (002144): Remaining honest: consolidating leading edge of scriptwriting, medical device development accelerates first “increase” in ratings
[Shenyin Wanguo Securities] Hongda Hi-Tech: Remaining serious, consolidating its leading edge, medical device development accelerates, and ratings “increase” for the first time
Hongda Hi-Tech (002144) Annual Report/Quarterly Report Review: Performance Meets Expectations, Diversified Expansion Sees Initial Results
[Guotai Junan Securities] Hongda Hi-Tech: Baijin increases elasticity, textile profits increase
[Cathay Pacific Junan Securities] Hongda Hi-Tech: Excellent starting performance, high growth trend determined
[Guotai Junan Securities] HTC: Dingzeng ultrasound equipment, open the growth space
[Tianxiang Investment] HTC: "B-ultrasound of interior fabric" constitutes performance double insurance.
[Guotai Junan Securities] HTC: a new army of equipment, spread its wings and take off
[Guotai Junan Securities] Hongda Tech: the grand plan is gradually developing, and the two swords are combined.
【广发证券】宏达高科:股价具有较强的安全边际,医疗器械领域的高成长可期
【广发证券】宏达高科:成功转型加速业绩提升,业绩承诺凸显安全边际
【天相投资】宏达高科:并表后盈利能力将逐步提升
【天相投资】宏达高科:投资收益大幅增加,重组资产值得期待
【长城证券】宏达经编:重组获得核准,不确定因素消除
【长城证券】宏达经编:纺织业务好转,医疗器械业务空间大
【天相投资】宏达经编:主业有好转,重组失败或成压力
【中投证券】宏达经编:09年公司业绩增长依然有限
【银河证券】宏达经编:定向增发带来外延式增长
【东海证券】宏达经编:汽车内饰有所回暖 多元化投资分散风险
No Data
No Data